Cargando…
Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy
Since the 1960s, a single class of agent has been licensed targeting virus-encoded ion channels, or ‘viroporins’, contrasting the success of channel blocking drugs in other areas of medicine. Although resistance arose to these prototypic adamantane inhibitors of the influenza A virus (IAV) M2 proton...
Autores principales: | Shaw, Joseph, Gosain, Rajendra, Kalita, Monoj Mon, Foster, Toshana L, Kankanala, Jayakanth, Mahato, D Ram, Abas, Sonia, King, Barnabas J, Scott, Claire, Brown, Emma, Bentham, Matthew J, Wetherill, Laura, Bloy, Abigail, Samson, Adel, Harris, Mark, Mankouri, Jamel, Rowlands, David J, Macdonald, Andrew, Tarr, Alexander W, Fischer, Wolfgang B, Foster, Richard, Griffin, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714397/ https://www.ncbi.nlm.nih.gov/pubmed/33169665 http://dx.doi.org/10.7554/eLife.52555 |
Ejemplares similares
-
Structure-Guided Design Affirms Inhibitors of Hepatitis C Virus p7 as a Viable Class of Antivirals Targeting Virion Release
por: Foster, Toshana L, et al.
Publicado: (2014) -
Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein
por: Kalita, Monoj Mon, et al.
Publicado: (2015) -
Viral channel forming proteins — How to assemble and depolarize lipid membranes in silico()
por: Fischer, Wolfgang B., et al.
Publicado: (2016) -
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza
por: Scott, Claire, et al.
Publicado: (2020) -
Editorial: Community series - innovative approaches in diagnosis of emerging/re-emerging infectious diseases, volume II
por: Foster, Toshana, et al.
Publicado: (2023)